Mucinous carcinoma of the breast (type B, ER+/PR-/Her2 3+) with chemoresistance (Herceptin)farukske2016-06-21T10:22:56+02:00June 21, 2016|Categories: Invasive carcinoma (NST)|Tags: Breast cancerMucinous carcinomaHer2ResistanceHerceptin| Figure 1. Her2 overexpression in the tumor cells [...] Read More